News
Newly prequalified Quality Control Laboratory (QCL)
New addition to the List of Prequalified Quality Control Laboratories (QCLs):
First flucytosine prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First dispersible paediatric ethambutol prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Riemser Pharma's protionamide prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Riemser Pharma's terizidone prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First rectal artesunate prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First dispersible paediatric levofloxacin tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Roche's ceftriaxone powder for injection prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
UPDATE: WHO Position paper on Qinhuangdao Zizhu Pharmaceutical Co Ltd, Active Pharmaceutical Ingredient (API) manufacturing site following the issue of the USFDA import alert
On 07 April 2017, WHO issued a position paper on the import alert placed on, Qinhuangdao Zizhu Pharmaceutical (QZP) by the United States Food and Drug Administration (USFDA) on 8 March 2017.
Hetero’s sofosbuvir tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Notice of Concern (NOC) withdrawn for Svizera Labs Pvt Ltd
Following corrective actions taken by Svizera Labs Pvt Ltd and the clarifications provided
Newly prequalified Active Pharmaceutical Ingredient (API)
Linezolid manufactured by Optimus Drugs Pvt Ltd has been
Temmler Pharma’s ethinylestradiol/levonorgestrel tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Hetero’s aciclovir tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Aurum Pharmaceuticals' magnesium sulfate injection prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Mylan’s cycloserine capsules prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Mylan’s capreomycin injection prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Shanghai Desano’s efavirenz tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Macleods’ linezolid tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Macleods’ paediatric rifampicin/isoniazid/pyrazinamide dispersible tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Strides Shasun's artemether/lumefantrine dispersible tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Laurus' tenofovir tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First entecavir prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First terizidone prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Pfizer’s medroxyprogesterone acetate 104mg/0.65mL suspension for injection (Sayana® Press) prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Hetero's abacavir/lamivudine tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Newly prequalified Active Pharmaceutical Ingredient (API)
Atazanavir (sulfate) manufactured by Macleods Pharmaceuticals Ltd has been prequalified by the WHO Prequalification Team: medicines under its API prequalification procedure.